Researchers have pinpointed a potent mechanism originating in the brain capable of triggering the rapid depletion of the body’s entire fat reserve, including stubborn fat deposits usually impervious to dieting and exercise. This process operates separately from the nervous system signals typically responsible for fat loss, instead relying on a specific state of low blood sugar coupled with low insulin levels. The findings of this study appeared in the journal Nature Metabolism.
Survival hinges on an organism’s capacity to store and mobilize calories during times of acute need. Most fat cells release energy in response to standard triggers like starvation or physical exertion. Nevertheless, humans and other mammals possess specialized populations of fat cells, termed stable adipocytes, which largely remain untouched by conventional calorie restriction or exercise measures.
These stable fat cells account for about 70 percent of the fat situated deep within human bone marrow. Scientists aimed to decipher why these specific fat cells resist typical weight-loss cues and how the body ultimately breaks them down under extreme duress. In severe states of fasting or debilitating illness, the body eventually consumes these stable fat reserves. Until now, the precise biological pathways governing this final phase of fat depletion remained obscured due to the lack of a reliable animal model.
“Certain body fat cells are persistent and resistant to diets and physical activity. We sought to determine the reason for this and how to eliminate them,” stated the study’s author, Erica L. Scheller from the University of Washington.
To investigate this phenomenon, the investigators devised a novel procedure enabling the swift induction of total fat loss in adult male mice aged 12 to 17 weeks. They continuously infused the hormone leptin, which generally regulates energy balance, directly into the mice’s brains.
This delivery was managed via microscopic pumps implanted under the skin and connected to the brain. The researchers administered leptin doses of 10 or 100 nanograms per hour continuously for nine days. They meticulously monitored the food intake of these mice, matching it precisely to a control group receiving an inert saline solution.
Over nine days, the mice receiving the highest brain-acting leptin dose exhibited an average weight loss of 19.3 percent of their body mass. This occurred despite consuming the exact equivalent amount of food as the control subjects. The scientists observed a distinct, cascading pattern of fat loss.
Subcutaneous fat deposits beneath the skin and around organs vanished within the first few days of the experiment. The stable fat hidden deep within the bone marrow proved significantly more recalcitrant to the treatment. This deep skeletal fat only disappeared completely by day nine in the mice subjected to the highest leptin dose.
Initially, the researchers hypothesized that local nerves or stress hormones, known as catecholamines, such as adrenaline, were driving this extreme fat loss. To test this, they surgically severed the sciatic nerve in one limb of several mice to disable the local nervous system. In a separate trial, they utilized a specific chemical agent to destroy sympathetic nerves throughout the bodies of another mouse cohort.
The scientists also examined genetically engineered mice, aged nine to twelve months, that were entirely unable to produce certain stress hormones. To their astonishment, interrupting nerve endings and stress hormones failed to prevent substantial fat loss. This suggested that the brain interfaces with these stable fat cells through an entirely different route—via the bloodstream.
Subsequent inquiry revealed that the sustained leptin infusion provoked a concurrent drop in both blood sugar and insulin levels in the mice. This specific physiological state is clinically known as hypoinsulinemic hypoglycemia.
To ascertain if this physical state was causative of the fat loss, the scientists implanted insulin pellets beneath the skin of a new group of leptin-treated mice. This artificial implant restored normal circulating insulin levels in the animals. Restoring insulin selectively protected the stable bone marrow fat from being broken down, although the regular body fat was still depleted. This indicated that the precise combination of low blood sugar and low insulin is requisite for mobilizing these tenacious fat stores.
“We were quite surprised that the activation of stable adipocyte loss in the brain occurred via signals in the blood and did not involve the peripheral nervous system,” Scheller noted. “This is distinct from the standard neural systems regulating conventional fat deposits.”
Next, the researchers analyzed the genetic makeup of these stable fat cells using advanced gene sequencing techniques. They found that under normal conditions, the stable fat cells produced abundant levels of specific proteins that function as internal brakes. One primary brake identified was the protein G0S2, which inhibits the internal cellular machinery responsible for breaking down stored fat.
When the mice experienced low blood sugar and insulin, the production of the G0S2 protein sharply diminished. Eliminating this internal brake finally allowed an enzyme called adipose triglyceride lipase to degrade the stored fat. This biological process is known as lipolysis—how the body converts stored fat into usable energy.
The research team observed the identical process in a separate group of mice experiencing severe weight loss driven by a tumor. They introduced colon cancer cells into 12-week-old adult mice to induce a severe wasting condition known as cachexia. During the final days of cancer progression in these mice, the same drop in blood sugar, insulin, and G0S2 protein was evident. This suggests that this newly identified biological mechanism represents a universal reaction to extreme physiological stress.
“In mice, activating the stable fat catabolism pathways results in the loss of all body fat within 9 days without any reduction in food intake,” stated Scheller. “In the future, titrating this effect could be utilized to develop obesity treatments and to preserve healthy fat reserves in patients suffering from cachexia and wasting disorders.”
While these findings elucidate how the body burns fat, the researchers cautioned against viewing this as a viable weight-loss strategy. These stable fat deposits typically provide crucial mechanical and structural support to vital body structures.
The depletion of these specialized fat cells is considered hazardous. In patients, fat loss from the bone marrow is linked to serious outcomes, such as bone fractures. A potential misinterpretation of the study is that standard diets might trigger this extreme fat loss, but the researchers pointed out that typical diets do not create the severe biological conditions necessary to activate this mechanism.
Since the study was conducted predominantly in mice, the exact timelines and biochemical thresholds might differ slightly in humans. Furthermore, the precise blood-borne signals interacting with the fat cells after the internal brakes are released remain uncertain. Scientists speculate that multiple circulating factors might operate in concert to complete the fat breakdown process.
The researchers hope that understanding this newly discovered biological mechanism will ultimately enable the development of targeted medical interventions. By blocking this specific fat-burning pathway, clinicians could maintain healthy fat stores in critically ill patients. This could ultimately enhance survival rates and the overall quality of life for these vulnerable individuals.
“Wasting is a debilitating consequence of conditions like cancer, chronic infections, and end-stage organ failure,” Scheller concluded. “Muscle atrophy and fat loss can diminish a patient’s capacity to tolerate necessary chemotherapy and treatment, thereby significantly increasing mortality risk. We hope to leverage this work to discover novel points of intervention to prevent pathological fat loss and improve survival.”
About the Author
